These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 8579894

  • 1. Present and future of osteoporosis therapy.
    Seeman E, Tsalamandris C, Bass S, Pearce G.
    Bone; 1995 Aug; 17(2 Suppl):23S-29S. PubMed ID: 8579894
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD, Wronski TJ.
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone.
    Hunziker J, Wronski TJ, Miller SC.
    J Dent Res; 2000 Jun; 79(6):1431-8. PubMed ID: 10890724
    [Abstract] [Full Text] [Related]

  • 8. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR, Bilezikian JP.
    Int J Fertil Womens Med; 2002 Jun; 47(3):103-15. PubMed ID: 12081255
    [Abstract] [Full Text] [Related]

  • 9. [Osteoporosis - Evidence based therapy].
    Minne HW, Begerow B, Pfeifer M.
    Z Gastroenterol; 2002 Apr; 40 Suppl 1():S57-S61. PubMed ID: 11930292
    [Abstract] [Full Text] [Related]

  • 10. Is cortical bone hip? What determines cortical bone properties?
    Epstein S.
    Bone; 2007 Jul; 41(1 Suppl 1):S3-8. PubMed ID: 17466615
    [Abstract] [Full Text] [Related]

  • 11. Strategies for the prevention and treatment of osteoporosis during early postmenopause.
    Delaney MF.
    Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S12-23. PubMed ID: 16448872
    [Abstract] [Full Text] [Related]

  • 12. [Indications and limitations of non-hormonal treatments of osteoporosis].
    Avouac B.
    Rev Fr Gynecol Obstet; 1993 Feb; 88(7-9):419-23. PubMed ID: 8235256
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Differential therapy of osteoporosis--an overview based on recent findings regarding the pathogenesis].
    Schacht E.
    Z Rheumatol; 1994 Feb; 53(5):274-98. PubMed ID: 7810237
    [Abstract] [Full Text] [Related]

  • 15. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis.
    McClung MR.
    Bone; 1996 Nov; 19(5 Suppl):195S-198S. PubMed ID: 8922662
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.